Donate to Gastrointestinal Cancer Research

Over 33,000 Australians are diagnosed with a from of GI cancer each year.

  • attach_money
  • person
  • credit_card

Support gastro-intestinal cancer research

I'd like to donate

Can help fund one hour of life-saving research
Can help pay for for microscopy to look for immune cells in tumours.
Can help provide lab supplies for up to ten vital experiments
Can help provide cutting-edge software to analyse cells

All payments are secured and encrypted.

Your Details

All payments are secured and encrypted.

Payment Details


I'd like to add a little extra to help cover fees.

All payments are secured and encrypted.

Help improve outcomes for gastro-intestinal cancer patients

Around 33,200 Australians are diagnosed with a form of GI cancer each year.

Cure Cancer has funded 33 gastro-intestinal cancer researchers so far, but more research is desperately needed. Supporting young researchers with innovative ideas gives us the best possible chance of finding a cure.

Every dollar you donate can make a real difference to our mission. Together, we can cure cancer.

"My project’s a fresh incentive which brings together collaborators with immunology and cancer expertise. Without this important funding from Cure Cancer, my work wouldn’t be possible"

— Dr Lisa Mielke, A Cure Cancer Grant Recipient

What is gastro-intestinal cancer?

Gastrointestinal cancer is a term for the group of cancers that affect the digestive system. These cancers occurs when abnormal cells in a specific part of the digestive system grow in an uncontrolled way. Gastrointestinal cancers are not sex-specific. Around 33,200 Australians are diagnosed with a form of GI cancer each year.

What are the types of gastro-intestinal cancer?

  • Oesophageal cancer
  • Liver cancer
  • Stomach cancer
  • Gallbladder & biliary tract cancer
  • Pancreatic cancer
  • Gastro-intestinal stromal tumour (GIST)
  • Neuroendocrine tumours (NETs)
  • Colorectal cancer
  • Small bowel cancer
  • Anal cancer

What are the common symptoms of gastro-intestinal cancer?

Some types of gastrointestinal cancer can be symptomless, making it difficult to detect in the early stages. However, any changes to the way your digestive system feels or operates should be discussed with your GP. Depending on the type of GI cancer, symptoms may include:

  • Stomach pain or bloating
  • Feeling of stomach fullness
  • Heartburn
  • Indigestion
  • Persistent nausea and vomiting
  • Loss of appetite
  • Unintentional weight Loss
  • Fatigue

How are gastro-intestinal cancers diagnosed?

The diagnosis of GI cancers vary depending on the type of cancer that is suspected. Your GP will perform an initial examination and may conduct a blood test. If necessary, they may then refer you for further tests. These might include:

  • An endoscopy to check the lining of the esophagus, stomach, and small intestine for tumors
  • A colonoscopy to check the colon and rectum for polyps
  • Imaging studies (MRI, X-ray, ultrasound, CT scan or PET scan) to check for abnormal tissue anywhere in the digestive system.
  • An endoscopic ultrasound
  • A biopsy to obtain a sample of abnormal tissue and analyse it for the presence of cancer cells.

    What is the prognosis for gastro-intestinal cancer?

    The prognosis for gastrointestinal cancer varies greatly, depending on which organ or area of the body is affected, and the stage of the cancer.

    An individual's prognosis also depends on the age and general health of the person at the time of diagnosis. Treatment is most effective if the cancer is found in its early stages.


    Our gastro-intestinal cancer researchers

    Together, we can cure cancer.

    How your donation helps


    Can fund an hour of research


    Can pay for microscopy imaging to look for immune cells in tumours


    Can fund small scale drug screening studies to identify new treatments


    Allows for comprehensive analysis of cancers through genomics

    Let's stay in touch

    To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.